APA (7th ed.) Citation

A, T., A, B., T, J., B, D., & A, G. (2026). Clinical progress and functional modalities of HDAC inhibitor-based combination therapies in cancer treatment. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 28(1), 71. https://doi.org/10.1007/s12094-025-03995-x

Chicago Style (17th ed.) Citation

A, Talom, Barhoi A, Jirpu T, Dawn B, and Ghosh A. "Clinical Progress and Functional Modalities of HDAC Inhibitor-based Combination Therapies in Cancer Treatment." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 28, no. 1 (2026): 71. https://doi.org/10.1007/s12094-025-03995-x.

MLA (9th ed.) Citation

A, Talom, et al. "Clinical Progress and Functional Modalities of HDAC Inhibitor-based Combination Therapies in Cancer Treatment." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, vol. 28, no. 1, 2026, p. 71, https://doi.org/10.1007/s12094-025-03995-x.